SecSonar.com

Bio Green Med Solution, Inc. (BGMS)

Bio Green Med Solution, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Bio Green Med Solution, Inc. (BGMS) is a Medical - Pharmaceuticals company based in US with a market capitalization of $2.3M. Revenue grew 1637.2% year-over-year and free cash flow was negative at -$4.8M. This page tracks BGMS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 12 employees · IPO Sep 12, 2025

Valuation

Valuation & price

$1.00 · as of May 17, 2026 · -83.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.34

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$6.02$3.31$0.60Sep 25Feb 26Jul 26Sep 12, 25$6.02Sep 15, 25$5.24Sep 17, 25$4.59Sep 19, 25$4.65Sep 22, 25$4.63Sep 24, 25$4.84Sep 26, 25$5.15Sep 29, 25$4.88Oct 1, 25$4.93Oct 3, 25$4.78Oct 6, 25$4.57Oct 8, 25$5.29Oct 10, 25$5.13Oct 13, 25$5.95Oct 15, 25$5.05Oct 17, 25$4.04Oct 20, 25$2.97Oct 22, 25$2.50Oct 24, 25$1.84Oct 27, 25$1.95Oct 29, 25$1.80Oct 31, 25$1.78Nov 4, 25$1.59Nov 5, 25$1.65Nov 7, 25$1.52Nov 11, 25$1.40Nov 12, 25$1.44Nov 14, 25$1.31Nov 18, 25$1.34Nov 19, 25$1.29Nov 21, 25$1.25Nov 25, 25$1.35Nov 26, 25$1.50Dec 1, 25$1.66Dec 3, 25$1.69Dec 4, 25$1.82Dec 8, 25$1.72Dec 10, 25$1.49Dec 11, 25$1.50Dec 15, 25$1.35Dec 17, 25$1.36Dec 19, 25$1.39Dec 22, 25$1.60Dec 24, 25$1.42Dec 29, 25$1.45Dec 30, 25$1.56Jan 2, 26$1.41Jan 6, 26$1.36Jan 7, 26$1.35Jan 9, 26$1.37Jan 13, 26$1.39Jan 14, 26$1.43Jan 16, 26$1.60Jan 21, 26$1.40Jan 22, 26$1.39Jan 26, 26$1.30Jan 28, 26$1.24Jan 29, 26$1.23Feb 2, 26$1.13Feb 4, 26$0.97Feb 6, 26$1.11Feb 9, 26$1.01Feb 11, 26$0.99Feb 13, 26$0.98Feb 17, 26$1.03Feb 19, 26$1.04Feb 23, 26$1.01Feb 24, 26$1.00Feb 26, 26$1.01Mar 2, 26$1.01Mar 3, 26$0.96Mar 5, 26$0.96Mar 9, 26$0.94Mar 10, 26$0.95Mar 12, 26$0.95Mar 16, 26$0.92Mar 17, 26$0.92Mar 19, 26$0.92Mar 23, 26$1.03Mar 24, 26$1.01Mar 26, 26$1.00Mar 30, 26$0.96Apr 1, 26$0.99Apr 2, 26$1.00Apr 7, 26$1.05Apr 9, 26$1.01Apr 10, 26$1.01Apr 14, 26$1.04Apr 16, 26$1.05Apr 17, 26$1.05Apr 21, 26$1.18Apr 23, 26$0.95Apr 24, 26$0.97Apr 28, 26$0.96Apr 30, 26$0.97May 1, 26$0.98May 5, 26$1.03May 7, 26$0.99May 8, 26$0.88May 12, 26$0.94May 14, 26$1.05May 18, 26$0.97May 19, 26$0.96May 21, 26$0.99May 26, 26$0.96May 27, 26$0.96May 29, 26$1.10Jun 2, 26$1.09Jun 3, 26$1.06Jun 5, 26$1.50Jun 9, 26$0.90Jun 10, 26$0.90Jun 12, 26$0.78Jun 16, 26$0.82Jun 17, 26$0.82Jun 22, 26$0.68Jun 24, 26$0.64Jun 25, 26$0.60Jun 29, 26$0.72Jul 2, 26$1.06
$0.6052-week range$6.02
Loading valuation history…

Fundamentals

Key fundamentals

$2.3M

Market cap

1637.2%

Revenue growth (YoY)

18.5%

Gross margin

-$4.8M

Free cash flow (USD)

-$3.5M

Net debt

Net cash position

9692.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$843.0KFY 2017$0.00FY 2018$150.0KFY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$420.0KFY 2024$43.0KFY 2025$747.0K
$843K$747K

Free cash flow by year

2016 → 2025

FY 2016$-10.1MFY 2017$-7.5MFY 2018$-6.7MFY 2019$-9.5MFY 2020$-8.0MFY 2021$-18.6MFY 2022$-20.8MFY 2023$-16.1MFY 2024$-8.0MFY 2025$-4.8M
-$10.1M-$4.8M

Gross margin by year

2023 → 2025

FY 2023100.0%FY 2024100.0%FY 202518.5%
100.0%18.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.04)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDividend DeclaredJul 1, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 22, 2026Filing
  • 8-K eventSecurities Purchase AgreementJun 10, 2026Filing
  • 8-K eventBusiness Combination AgreementJun 4, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • 8-K eventDividend DeclaredApr 13, 2026Filing

Questions

Frequently asked questions

What is Bio Green Med Solution, Inc.'s market cap?

Bio Green Med Solution, Inc. (BGMS) has a market capitalization of $2.3M.

What is BGMS's P/E ratio?

A meaningful P/E ratio is not available for BGMS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is BGMS's price-to-book (P/B) ratio?

BGMS trades at 0.34 times book value per share.

When did Bio Green Med Solution, Inc. last report earnings?

BGMS last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying BGMS stock?

SEC Form 4 filings show no open-market insider buys at Bio Green Med Solution, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Pharmaceuticals

HKPD

Cellyan Biotechnology Co., Ltd

$5.7M

POM

POMDOCTOR Ltd

$12.7M

KYNB

Kyntra Bio, Inc.

$28.1M

NEUP

Neuphoria Therapeutics Inc.

$28.6M

SDEV

Stablecoin Development Corp.

$35M

PETS

PetMed Express, Inc.

$46.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.